COLLEGIUM PHARMACEUTICAL, INC (COLL) › Operating IncomeCOLLEGIUM PHARMACEUTICAL, INC (COLL) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$16.04M2014: -$17.66M2015: -$26.91M2016: -$94.08M2017: -$75.45M2018: -$20.68M2019: -$23.75M2020: $56.23M2021: $17.63M2022: $33.32M2023: $166.96M2024: $169.90M2025: $179.64M$179.64M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$179.64M+5.7%2024$169.90M+1.8%2023$166.96M+401.1%2022$33.32M+89.0%2021$17.63M-68.7%2020$56.23M+336.8%2019-$23.75M-14.8%2018-$20.68M+72.6%2017-$75.45M+19.8%2016-$94.08M-249.7%2015-$26.91M-52.3%2014-$17.66M-10.1%2013-$16.04M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share